ACRS

ACRS Other Income/Expenses (Net)

$10.58MTTM · USD

Period ending:

ACRS FY Other Income/Expenses (Net)USD
ACRS FY Other Income/Expenses (Net)2013-12-31: $21.00K2014-12-31: $16.00K2015-12-31: $104.00K2016-12-31: $488.00K2017-12-31: -$15.99M2018-12-31: $2.68M2019-12-31: -$2.48M2020-12-31: -$424.00K2021-12-31: -$1.14M2022-12-31: $2.95M2023-12-31: $8.51M2024-12-31: $9.87M2025-12-31: $11.45M$11.45M-$15.99M
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ACRS other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Aclaris Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
11,452,000
9,867,000
8,509,000
2,946,000
-1,142,000
-424,000
-2,484,000
2,676,000
-15,992,000
488,000
104,000
16,000
21,000

Compare other income/expenses (net)

All ACRS financial metrics · ACRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.